RxDoctor Payments Data

Brian Zimmerman, DPM

Podiatrist · Mansfield, OHNPI 1376586651

Payments from drug & device makers

$2,095in general payments, 2019–2025

Across 47 payments — averaging $44.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$897
  • Smith+Nephew$463
  • Johnson & Johnson$164
  • Stryker$79
  • Bioventus LLC$77
  • Organogenesis Inc.$70
  • plus $345 from 11 others

What the payments were for

  • Travel & lodging$76937%
  • Food & beverage$1,32663%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,095 in reported general payments places this provider in the 65th percentile of 397 podiatrist providers in Ohio.

See all podiatrist providers in Ohio

Medicare billing

Part B allowed, 2024
$157,847
Medicare patients
358
Services billed
2,421

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban49$23,162
XareltoRivaroxaban14$7,901
Ciclopirox152$4,050
Doxycycline Hyclate295$2,185
Ammonium Lactate88$1,455
Celecoxib12$895
Pregabalin40$855
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip50$668
Gabapentin85$394
Meloxicam170$392
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav54$385
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen54$342
Colchicine23$319
Cephalexin50$306
Levofloxacin35$304

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$164$7,90114 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 397 podiatrist providers in Ohio.

Other podiatrist in Mansfield

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →